{"nct_id":"NCT05026866","title":"A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2021-08-27","start_date_type":"ACTUAL","primary_completion_date":"2027-11","primary_completion_date_type":"ESTIMATED","completion_date":"2027-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}